Lotus Pharmaceuticals (LTUS) Financial Statements
Lotus Pharmaceuticals Financial Overview
Lotus Pharmaceuticals's market cap is currently $112.66K. The company's EPS TTM is $0.00; its P/E ratio is -355.29; Lotus Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -18.81K | $ -21.11K | $ -30.41K | $ -6.28K | $ -21.83K |
| EBITDA | $ -18.81K | $ -21.11K | $ -30.41K | $ -6.28K | $ -21.83K |
| Net Income | $ -18.81K | $ -21.11K | $ -30.41K | $ -6.28K | $ -21.83K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.90K | $ 1.15K | $ 7.67K | $ 1.74K | $ 31.00 |
| Total Assets | $ 5.68K | $ 4.81K | $ 7.67K | $ 1.74K | $ 8.54K |
| Total Debt | $ 116.68K | $ 96.80K | $ 75.64K | $ 39.30K | $ 30.37K |
| Net Debt | $ 114.78K | $ 95.65K | $ 67.97K | $ 37.55K | $ 30.34K |
| Total Liabilities | $ 116.68K | $ 97.00K | $ 75.64K | $ 39.30K | $ 30.37K |
| Stockholders' Equity | $ -111.00K | $ -92.19K | $ -67.97K | $ -37.55K | $ -21.83K |
| Cash Flow | |||||
| Free Cash Flow | $ -19.13K | $ -23.82K | $ -30.41K | $ -6.28K | $ -21.83K |
| Operating Cash Flow | $ -19.13K | $ -23.82K | $ -30.41K | $ -6.28K | $ -21.83K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 8.51K |
| Financing Cash Flow | $ 19.88K | $ 17.30K | $ 36.34K | $ 8.00K | $ 30.37K |
Currency in USD
